RETAKLIK
RETA-30
Prefilled Klik-Pen
Retatrutide is a triple GIP/GLP-1/Glucagon receptor agonist, the first of its class, delivered in a once-weekly prefilled Klik-pen.
Scientific Specifications
Triple GIP/GLP-1/GCGR agonistProduct Details
RETAKLIK contains retatrutide (LY3437943), a novel triple-acting receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Each pen contains 30mg/2.4ml (4 doses of 7.5mg). The glucagon receptor component adds thermogenic and lipolytic effects beyond what dual agonists achieve. Phase 2 clinical data demonstrated unprecedented weight reduction of up to 24% at 48 weeks. Research focuses on obesity, NASH/MAFLD, and metabolic syndrome.
Related Products
All products are sold strictly for research and laboratory use only. Not for human consumption. By purchasing, you agree to use these products only for legitimate research purposes.